# Phase 2 Completion Report

## Scope

Phase 2 adds deterministic XBRL financial analysis to the SEC ingestion actor.

## Delivered

- SEC Company Facts fetching with 24-hour caching and concept filtering
- Canonical US-GAAP metric mappings with fallback concepts
- XBRL fact normalization with units and confidence scores
- Financial period resolution and compatibility checks
- QoQ and YoY change calculations, significance classification, and derived metrics
- Optional actor integration through `analysis.financials`
- 39 focused Phase 2 tests; 70 tests pass across the project

## Validation

- `npm run build` passes with TypeScript strict mode enabled
- `npm test` passes with 70 tests

## Output

When `analysis.financials` is enabled, the actor emits `PHASE_2_XBRL_ANALYSIS`
metadata plus normalized `metrics` and `financialChanges` fields. XBRL values
remain traceable to their source concept, filing date, accession number, and
confidence score.